These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Importance of AFP screening in the early detection of low-weight infants]. Bognár Z; Csaba I; Arany A; Veszprémi B; Pejtsik B Orv Hetil; 1984 Jun; 125(25):1497-9. PubMed ID: 6205347 [No Abstract] [Full Text] [Related]
4. Prenatal diagnosis of prune belly syndrome by means of raised maternal AFP levels. Pescia G; Cruz JM; Weihs D J Genet Hum; 1982 Oct; 30(3):271-4. PubMed ID: 6185634 [No Abstract] [Full Text] [Related]
5. [Prenatal investigations for Down's syndrome: medical-technical considerations and dilemmas arising from current screening methods]. Grijseels EW; Laudy JA; Galjaard RJ; Wildschut HI Ned Tijdschr Geneeskd; 2004 Oct; 148(44):2166-71. PubMed ID: 15559409 [TBL] [Abstract][Full Text] [Related]
6. FDA lifts restrictions on AFP test for fetal screening. MLO Med Lab Obs; 1983 Aug; 15(8):27-9. PubMed ID: 10315384 [No Abstract] [Full Text] [Related]
7. Maternal serum triple analyte screening in pregnancy. Graves JC; Miller KE; Sellers AD Am Fam Physician; 2002 Mar; 65(5):915-20. PubMed ID: 11898965 [TBL] [Abstract][Full Text] [Related]
8. Prenatal screening: current policy in EC countries. Heringa M; Huisjes HJ Eur J Obstet Gynecol Reprod Biol; 1988 Apr; 28 Suppl():7-52. PubMed ID: 3384169 [No Abstract] [Full Text] [Related]
9. [A study on the screening of prenatal trisomy 21 using the fucosylated alpha-fetoprotein ratio measured by a liquid-phase binding assay]. Minobe S Hokkaido Igaku Zasshi; 2002 Nov; 77(6):527-32. PubMed ID: 12491624 [No Abstract] [Full Text] [Related]
10. Using automated prenatal screening assays in the clinical laboratory. Blacklaw M Am Clin Lab; 2000; 19(1):14. PubMed ID: 10848433 [No Abstract] [Full Text] [Related]
11. Which gestational age estimate to use in AFP screening for spina bifida? Wald NJ Prenat Diagn; 2005 Jul; 25(7):623. PubMed ID: 16034829 [No Abstract] [Full Text] [Related]
12. [Prenatal screening for Down syndrome: from sequential to combined estimated risk]. Jouannic JM; Benifla JL Gynecol Obstet Fertil; 2006 Jun; 34(6):467-9. PubMed ID: 16716636 [No Abstract] [Full Text] [Related]
13. Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers. Wald NJ; Morris JK; Ibison J; Wu T; George LM Prenat Diagn; 2006 Jun; 26(6):559-64. PubMed ID: 16700087 [TBL] [Abstract][Full Text] [Related]
15. Recurrent false-positives in AFP screening for open neural tube defects. Wald NJ; Huttly WJ; Rudnicka AR Prenat Diagn; 2004 Dec; 24(12):1018-9. PubMed ID: 15614882 [No Abstract] [Full Text] [Related]
16. Evaluation of effect of analytical imprecision in maternal serum screening for Down's syndrome. Spencer K Ann Clin Biochem; 2001 Jul; 38(Pt 4):413-4. PubMed ID: 11471889 [No Abstract] [Full Text] [Related]
17. [Multiple of the median and its uses in antenatal screening]. Jiangsu Province Birth Planning Commitee Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):428-9. PubMed ID: 15312334 [No Abstract] [Full Text] [Related]
18. Maternal serum alpha-fetoprotein screening. American Public Health Association Am J Public Health; 1991 Feb; 81(2):241-2. PubMed ID: 11642861 [No Abstract] [Full Text] [Related]
19. New trends in prenatal screening for chromosomal abnormalities. Addar MH Saudi Med J; 2000 May; 21(5):429-32. PubMed ID: 11500675 [TBL] [Abstract][Full Text] [Related]
20. [Prioritization and the "triple"-test in prenatal diagnosis]. Pedersen KM Ugeskr Laeger; 1999 Dec; 161(50):6901. PubMed ID: 10643374 [No Abstract] [Full Text] [Related] [Next] [New Search]